查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1520617

eClinical解決方案的全球市場的評估:各產品，提供方式，各臨床試驗階段，各終端用戶，各地區，機會，預測(2017年～2031年)

eClinical Solutions Market Assessment, By Product, By Mode of Delivery, By Clinical Trial Phase, By End-user, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

全球電子臨床解決方案市場規模預計將從 2023 年的 100.1 億美元增至 2031 年的 268.1 億美元，預計在 2024-2031 年預測期內複合年增長率為 13.11%。由於多種因素，預計市場將在預測期內成長。

術語 "電子臨床解決方案" 描述了在臨床研究中使用技術來組織和評估臨床數據。這些方法有助於簡化臨床試驗程序並提高其速度、有效性和準確性。其中一些系統包括電子病患報告結果 (ePRO)、隨機化和研究藥物供應管理 (RTSM)、電子資料收集 (EDC) 和臨床試驗管理系統 (CTMS)。市場擴張的主要原因是對技術先進的臨床試驗管理系統的需求不斷增長。因此，EDC 和臨床數據管理系統（CDMS 系統）的快速採用、對遠距醫療和遠端患者監控不斷增長的需求正在對市場產生積極影響。此外，臨床試驗數量的增加和快速治療需求的增加也刺激了市場。除此之外，對準確可靠的數據的需求不斷增長以及對臨床試驗數據發展的監管審查正在推動市場發展。此外，透過避免紙本程序並減少人工資料輸入的需要，電子臨床解決方案可以減少與臨床試驗管理相關的費用。預計這將進一步加速市場擴張。此外，該行業還受益於以患者為中心的研究日益重要以及基於雲端的解決方案的快速採用。此外，透過人工智慧和機器學習 (ML) 演算法的不斷集成，以發現數據模式和趨勢並增強決策，該行業正在加強。市場的其他驅動因素包括生物製藥行業的大幅擴張、慢性病盛行率上升、人口老化、智慧醫療設備的使用增加以及醫療保健系統基礎設施的持續改善。例如，2023 年 12 月，Obvio Health USA, Inc. 宣布推出最先進的電子臨床結果評估 (eCOA) 解決方案。該解決方案將臨床和科學服務與最先進的試驗設計技術相結合，產生可靠的試驗結果。技術在推動 eCOA 方面發揮著重要作用。借助它的幫助，您可以加快試驗計劃並簡化結果捕獲。然而，技術只是有效的 eCOA 計劃的要素之一。只有將聰明、科學的試驗設計與富有同情心的患者支持相結合，我們才能真正實現以患者為中心並提供更好的證據。

臨床試驗複雜性的增加促使市場擴張

電子臨床解決方案市場正在經歷顯著成長，這主要是由於臨床試驗的複雜性不斷增加。現代臨床試驗需要複雜的數據管理和分析技術，以適應複雜的程序、異質的患者群體和多維度的監管要求。電子臨床解決方案，包括電子病患報告結果 (ePRO)、臨床試驗管理系統 (CTMS) 和電子資料擷取 (EDC)，可滿足這些需求。這些解決方案提高了數據準確性，簡化了數據收集，並加強了監管合規性。 eClinical 解決方案提供整合系統，可實現即時監控和無縫資料集成，從而實現更有效的臨床試驗管理和更快的決策。

這些效率對於尋求更快地將新療法推向市場的製藥公司至關重要，因為它們最終會降低成本並改善患者的治療效果。

此外，現代臨床試驗在世界各地進行，因此找到適用於許多監管環境和地理位置的解決方案至關重要。 eClinical 解決方案提供監督國際臨床試驗所需的規模和適應性，確保所有臨床試驗地點的法規遵循和統一的數據標準。

本報告提供全球eClinical解決方案市場調查分析，提供市場規模與預測，市場動態，主要企業的形勢及預測等資訊。

目錄

第1章 調查手法

第2章 計劃的範圍和定義

第3章 摘要整理

第4章 全球eClinical解決方案市場預測(2017年～2031年)

  • 市場規模與預測
    • 金額
  • 各產品
    • 臨床資料管理系統(CDMS)
    • 臨床試驗管理系統(CTMS)
    • 非人為化·臨床實驗藥供給管理
    • 電子資料收集(EDC)
    • 電子臨床療效評估(eCOA)
    • 電子病人報告結果(ePRO)
    • 臨床分析平台
    • 電子臨床實驗相關文件(eTMF)
    • 其他
  • 發送方式
    • 網站主人模式
    • 許可證企業模式
    • 雲端基礎解決方案
  • 各臨床試驗階段
    • 階段I
    • 階段II
    • 階段III
    • 階段IV
  • 各終端用戶
    • 製藥企業，生物醫藥品企業
    • 臨床研究委外機構(CRO)
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 市場佔有率:各企業(2023年)

第5章 全球eClinical解決方案市場預測:各地區(2017年～2031年)

  • 北美
    • 市場規模與預測
    • 各產品
    • 發送方式
    • 各臨床試驗階段
    • 各終端用戶
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 俄羅斯
    • 荷蘭
    • 西班牙
    • 土耳其
    • 波蘭
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 澳洲
    • 越南
    • 韓國
    • 印尼
    • 菲律賓
  • 南美
    • 巴西
    • 阿根廷
  • 中東·非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第6章 市場製圖(2023年)

  • 各產品
  • 發送方式
  • 各臨床試驗階段
  • 各終端用戶
  • 各地區

第7章 宏觀環境和產業結構

  • 供需分析
  • 價值鏈分析
  • PESTEL分析
  • 波特的五力分析

第8章 市場動態

  • 成長促進因素
  • 阻礙成長的要素(課題，阻礙因素)

第9章 法規結構和革新

  • 專利形勢
  • 法規當局的認證
  • 革新/新技術

第10章 主要企業的形勢

  • 市場領導者前五名公司的競爭矩陣
  • 市場領導者前五名公司的市場收益的分析(2023年)
  • 合併和收購/合資企業(如果符合)
  • SWOT分析(市場企業5公司)
  • 專利分析(如果符合)

第11章 案例研究

第12章 主要企業預測

  • Oracle Corporation
  • Dassault Systemes
  • Parexel International Corporation
  • Clario
  • ICON plc
  • Signant Health
  • MaxisIT Inc.
  • 4G Clinical
  • Veeva Systems Inc.
  • eClinical Solutions LLC

第13章 策略性推薦

第14章 本公司相關資料，免責聲明

Product Code: MX11639

Global eClinical solutions market is projected to witness a CAGR of 13.11% during the forecast period 2024-2031, growing from USD 10.01 billion in 2023 to USD 26.81 billion in 2031. The market is expected to grow in the forecast period due to several underlying factors.

The term "eClinical solutions" describes the use of technology in clinical research to organize and evaluate clinical data. These methods aid in streamlining the clinical trial procedure, increasing its speed, effectiveness, and accuracy. Among these systems are electronic patient-reported outcomes (ePRO), randomization and trial supply management (RTSM), electronic data capture (EDC), and clinical trial management systems (CTMS). The market is expanding mostly due to the growing need for technologically sophisticated clinical trial management systems. Accordingly, the market is being positively impacted by the quick uptake of EDC and clinical data management system CDMS systems, as well as the expanding need for telemedicine and remote patient monitoring. In addition, the market is being stimulated by an increasing number of clinical trials and a growing demand for fast medical treatment. Apart from this, the market is being driven by the increasing need for precise and dependable data and the regulatory scrutiny over developing clinical trial data. Moreover, by avoiding paper-based procedures and reducing the need for human data entry, eClinical solutions can lower the expenses related to clinical trial management. It is anticipated that this will further fuel the market's expansion. In addition, the industry is benefiting from the growing significance of patient-centric studies and the fast adoption of cloud-based solutions. Furthermore, the industry is being strengthened by the increasing integration of artificial intelligence (AI) and machine learning (ML) algorithms to find patterns and trends in data and enhance decision-making. Additional factors propelling the market include the biopharmaceutical industries' notable expansion, the rise in chronic disease prevalence, the aging population, the growing use of smart medical devices, and ongoing infrastructure improvements in the healthcare system. For instance, Obvio Health USA, Inc. unveiled a cutting-edge electronic clinical outcome assessment (eCOA) solution in December 2023 that combines clinical and scientific services with cutting-edge study design technology to produce reliable trial results. Technology plays a major role in facilitating eCOA. Study schedules can be expedited, and outcomes capture can be simplified with its assistance. However, technology is only one element of an effective eCOA plan. One can only truly attain patient centricity and present better evidence when combined with smart, scientific study design and compassionate patient assistance.

Increasing Complexity of Clinical Trials Leading to Market Expansion

The market for eClinical solutions is growing at a substantial rate, mostly due to the increasing complexity of clinical trials. Sophisticated data management and analysis technologies are required for the complex procedures, heterogeneous patient groups, and multidimensional regulatory requirements of modern clinical trials. These needs are met by eClinical solutions, which include electronic patient-reported outcomes (ePRO), clinical trial management systems (CTMS), and electronic data capture (EDC). These solutions improve data accuracy, streamline data collection, and increase regulatory compliance. Managing massive volumes of data from several sources, such as wearables, electronic health records (EHR), and genomic data, gets harder as clinical trials get more complicated. eClinical solutions provide integrated systems that enable real-time monitoring and seamless data integration, leading to more effective trial management and quicker decision-making.

This efficiency is essential for pharmaceutical companies hoping to shorten the time it takes to bring new treatments to market since it will eventually save money and enhance patient outcomes..

Furthermore, because modern clinical trials are conducted worldwide, it is imperative to find solutions that can function in many regulatory environments and geographical locations. eClinical solutions offer the scale and adaptability required to oversee international trials, guaranteeing regulatory compliance and uniform data standards at every trial location. Further increasing demand for eClinical solutions is owed to the COVID-19 pandemic, which has led to the rising adoption of remote and decentralized trial methodologies. By providing digital data collection, telemedicine consultations, and remote patient monitoring, these technologies facilitate virtual trial designs and ensure trial continuity even times of disruptions. In summary, the escalating complexity of clinical trials is propelling the growth of the eClinical solutions market by demanding more advanced, integrated, and flexible data management and analysis tools, which in turn enhance trial efficiency, compliance, and overall success.

For instance, the most recent version of ICON plc's Digital Platform, which facilitates the smooth integration of sponsor, site, and patient services with harmonized data delivery, was unveiled in June 2023. The platform is adaptable for a range of therapeutic areas and study designs, offering end-to-end solutions for patient services in clinical trials. Features include an easy-to-use mobile app, direct data capture for in-home services, eCOA, telehealth visits, eConsent, and digital health technology management.

Growth in Market Due to Adoption of Web-based eClinical Solutions

The eClinical solutions market is growing at a substantial rate due to the use of web-based eClinical solutions. These technologies provide several advantages over conventional techniques, such as using the Internet to facilitate and streamline clinical trials. One of the most important benefits is improved data management. Real-time data access and capture are made possible by web-based eClinical solutions, which increase data handling efficiency and accuracy. Additionally, its real-time capabilities speed up decision-making, allowing faster trial modifications and results. Web-based platforms also provide better flexibility and scalability. They can be easily expanded and updated to meet the needs of both big international trials and small-scale investigations, regardless of the size and complexity of the trials. This flexibility is essential as clinical studies get bigger and more complex. Another driving force is cost-effectiveness; web-based solutions save operating costs by avoiding the need for manual processes and physical infrastructure. Due to their low cost, more organizations, including academic institutions and smaller biotech firms, can afford to use modern eClinical tools, expanding the industry. Furthermore, these solutions improve stakeholder collaborations as well. Trial operations are more unified and well-coordinated when sponsors, investigators, and regulatory agencies can exchange information and interact with ease. This cooperative setting encourages creativity and speeds up the creation of novel treatments. Web-based eClinical solutions are becoming increasingly popular as a result of the increased focus on patient-centric approaches in clinical research. These solutions provide virtual trials and remote monitoring, which improve patient convenience and boost recruitment and retention rates. Overall, the integration of web-based eClinical solutions into the clinical trial process is driving market growth by offering efficiency, scalability, cost savings, and improved collaboration, thereby transforming the landscape of clinical research. The extension of eClinical Solutions LLC.'s ML and AI capabilities within the elluminate IQ platform was announced in May 2023. These state-of-the-art ML/AL capabilities allow data management teams to conduct more scalable and efficient data reviews.

Increasing Dominance of Clinical Data Management Segment Leading to Market Growth

A crucial stage in clinical research is clinical data management (CDM), which produces high-quality, dependable, and statistically sound data from clinical trials. This contributes to a significant reduction in the time taken between drug development and marketing. The integration of the CDM with supply management, trial, clinical randomization, and patient recruiting systems is a key trend propelling this market. Additionally, businesses are improving their current eClinical technologies to increase their functionality and make conducting clinical trials an easy process. Furthermore, considering the complexity of data management procedures in clinical trials for diabetes and the pervasive use of information technologies, a study published in the Journal of Healthcare Engineering in February 2022 states that the use of clinical data management systems in these trials appears inevitable. Software that helps with data management during clinical trials and reduces the chances of errors that might happen when data is manipulated manually. Over the course of the projection period, it is expected that the advantages of clinical data management in clinical trials will propel segment expansion. Furthermore, significant market players' developments are fostering segment growth.

For instance, Veeva Systems Inc. stated in February 2022 that Idorsia Pharmaceuticals Ltd. had added Veeva Vault CDM for electronic data capture (EDC) and coding to its list of applications using Veeva Vault Clinical Suite.

Asia-Pacific to Dominate the eClinical Solutions Market

Due to significant unmet medical requirements and the increased prevalence of chronic diseases like cancer, cardiovascular problems, and infectious diseases, Asia-Pacific is expected to achieve promising growth throughout the projection period. Owing to their vast patient populations and low costs, China, India, Korea, and Japan are seeing an increase in the number of studies that are outsourced to them. Government funding for drug development and research is a major factor driving the growth of the Asia-Pacific market, which is expected to continue to rise over the projected period despite being an emerging economy.

The Ministry of Health and Family Welfare (MoHFW) in India received an allocation of USD 10.5 billion (INR 86,201 crore) for 2022-2023; of which, the Department of Health Research in India received USD 391 million (INR 3,201 crore) for research purposes in 2022, according to data published by the Policy Research Studied (PRS) Legislative Research. As a result, an increase in government financing for medical development and research is driving up market growth overall. The advancements made by different industry participants are also contributing to the expansion of the market. One of the top Japanese clinical trial companies, 3H Medi Solution Inc., announced in February 2023 that it had chosen THREAD research to increase decentralized research capacity and enhance patient access to clinical research in Japan. THREAD's tested technology platform and advisory services, along with 3H Medi Solution Inc.'s extensive recruitment, home visit assistance, and general clinical research delivery skills, provide clients with improved options. Such technological advancements in the region lead to growth and fuel market expansion.

Future Market Scenario (2024-2031F)

The global eClinical solutions market, which is growing in significance as the healthcare industry undergoes a digital transformation, is influencing the direction of clinical research and patient care in the future. eClinical technologies, which combine state-of-the-art data analytics, cloud computing, and innovative software platforms, are revolutionizing clinical trials, increasing data accuracy, and speeding up the drug development process. The main factors contributing to the anticipated growth of the eClinical solutions market are the increasing complexity of clinical trials and the rising problems associated with data management. Not only this, but the rising adoption of cloud-based and web-based solutions is a significant factor contributing to the growth of this market in the forecast period. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. In January 2023, oral dosage form-focused contract development and manufacturing organization (CDMO) Adare Pharma Solutions selected Veeva Systems Inc.'s Veeva Vault Quality Suite to standardize quality systems throughout the entire enterprise.

Key Players Landscape and Outlook

Several companies, such as Oracle Corporation, Dassault Systemes, Parexel International Corporation, Clario, ICON plc, Signant Health, MaxisIT Inc., 4G Clinical, Veeva Systems Inc., eClinical Solutions LLC, etc., are expanding their businesses by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed eClinical solutions to help researchers and strengthen their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments, and partnerships are a few ways through which they are trying to achieve the same.

For instance, Syneos Health and uMotif Limited partnered in June 2023, utilizing a cutting-edge digital platform with strong electronic clinical outcome assessment (eCOA) and electronic patient-reported outcomes (ePRO) functionalities. Through this collaboration, clinical trials will become quicker, leading to more effective patient delivery of innovative drugs.

Table of Contents

1. Research Methodology

2. Project Scope and Definitions

3. Executive Summary

4. Global eClinical Solutions Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. By Product
    • 4.2.1. Clinical Data Management Systems (CDMS)
    • 4.2.2. Clinical Trial Management Systems (CTMS)
    • 4.2.3. Randomization and Trial Supply Management
    • 4.2.4. Electronic Data Capture (EDC)
    • 4.2.5. Electronic Clinical Outcome Assessments (eCOA)
    • 4.2.6. Electronic Patient-reported Outcomes (ePRO)
    • 4.2.7. Clinical Analytics Platforms
    • 4.2.8. Electronic Trial Master File (eTMF)
    • 4.2.9. Others
  • 4.3. By Mode of Delivery
    • 4.3.1. Web-Hosted Models
    • 4.3.2. Licenced-Enterprise Models
    • 4.3.3. Cloud-Based Solutions
  • 4.4. By Clinical Trial Phase
    • 4.4.1. Phase I
    • 4.4.2. Phase II
    • 4.4.3. Phase III
    • 4.4.4. Phase IV
  • 4.5. By End-user
    • 4.5.1. Pharmaceutical and Biopharmaceutical Companies
    • 4.5.2. Contract Research Organisations
    • 4.5.3. Others
  • 4.6. By Region
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia-Pacific
    • 4.6.4. South America
    • 4.6.5. Middle East and Africa
  • 4.7. By Company Market Share (%), 2023

5. Global eClinical Solutions Market Outlook, By Region, 2017-2031F

  • 5.1. North America*
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
    • 5.1.2. By Product
      • 5.1.2.1. Clinical Data Management Systems (CDMS)
      • 5.1.2.2. Clinical Trial Management Systems (CTMS)
      • 5.1.2.3. Randomization and Trial Supply Management
      • 5.1.2.4. Electronic Data Capture (EDC)
      • 5.1.2.5. Electronic Clinical Outcome Assessments (eCOA)
      • 5.1.2.6. Electronic Patient-reported Outcomes (ePRO)
      • 5.1.2.7. Clinical Analytics Platforms
      • 5.1.2.8. Electronic Trial Master File (eTMF)
      • 5.1.2.9. Others
    • 5.1.3. By Mode of Delivery
      • 5.1.3.1. Web-Hosted Models
      • 5.1.3.2. Licenced-Enterprise Models
      • 5.1.3.3. Cloud-Based Solutions
    • 5.1.4. By Clinical Trial Phase
      • 5.1.4.1. Phase I
      • 5.1.4.2. Phase II
      • 5.1.4.3. Phase III
      • 5.1.4.4. Phase IV
    • 5.1.5. By End-user
      • 5.1.5.1. Pharmaceutical and Biopharmaceutical Companies
      • 5.1.5.2. Contract Research Organisations
      • 5.1.5.3. Others
    • 5.1.6. United States*
      • 5.1.6.1. Market Size & Forecast
        • 5.1.6.1.1. By Value
      • 5.1.6.2. By Product
        • 5.1.6.2.1. Clinical Data Management Systems (CDMS)
        • 5.1.6.2.2. Clinical Trial Management Systems (CTMS)
        • 5.1.6.2.3. Randomization and Trial Supply Management
        • 5.1.6.2.4. Electronic Data Capture (EDC)
        • 5.1.6.2.5. Electronic Clinical Outcome Assessments (eCOA)
        • 5.1.6.2.6. Electronic Patient-reported Outcomes (ePRO)
        • 5.1.6.2.7. Clinical Analytics Platforms
        • 5.1.6.2.8. Electronic Trial Master File (eTMF)
        • 5.1.6.2.9. Others
      • 5.1.6.3. By Mode of Delivery
        • 5.1.6.3.1. Web-Hosted Models
        • 5.1.6.3.2. Licenced-Enterprise Models
        • 5.1.6.3.3. Cloud-Based Solutions
      • 5.1.6.4. By Clinical Trial Phase
        • 5.1.6.4.1. Phase I
        • 5.1.6.4.2. Phase II
        • 5.1.6.4.3. Phase III
        • 5.1.6.4.4. Phase IV
      • 5.1.6.5. By End-user
        • 5.1.6.5.1. Pharmaceutical and Biopharmaceutical Companies
        • 5.1.6.5.2. Contract Research Organisations
        • 5.1.6.5.3. Others
    • 5.1.7. Canada
    • 5.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. Asia-Pacific
    • 5.3.1. India
    • 5.3.2. China
    • 5.3.3. Japan
    • 5.3.4. Australia
    • 5.3.5. Vietnam
    • 5.3.6. South Korea
    • 5.3.7. Indonesia
    • 5.3.8. Philippines
  • 5.4. South America
    • 5.4.1. Brazil
    • 5.4.2. Argentina
  • 5.5. Middle East and Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Product
  • 6.2. By Mode of Delivery
  • 6.3. By Clinical Trial Phase
  • 6.4. By End-user
  • 6.5. By Region

7. Macro Environment and Industry Structure

  • 7.1. Demand Supply Analysis
  • 7.2. Value Chain Analysis
  • 7.3. PESTEL Analysis
    • 7.3.1. Political Factors
    • 7.3.2. Economic System
    • 7.3.3. Social Implications
    • 7.3.4. Technological Advancements
    • 7.3.5. Environmental Impacts
    • 7.3.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.4. Porter's Five Forces Analysis
    • 7.4.1. Supplier Power
    • 7.4.2. Buyer Power
    • 7.4.3. Substitution Threat
    • 7.4.4. Threat From New Entrant
    • 7.4.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Patent Landscape
  • 9.2. Regulatory Approvals
  • 9.3. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (By Value, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Case Studies

12. Key Players Outlook

  • 12.1. Oracle Corporation
    • 12.1.1. Company Details
    • 12.1.2. Key Management Personnel
    • 12.1.3. Products and Services
    • 12.1.4. Financials (As Reported)
    • 12.1.5. Key Market Focus and Geographical Presence
    • 12.1.6. Recent Developments
  • 12.2. Dassault Systemes
  • 12.3. Parexel International Corporation
  • 12.4. Clario
  • 12.5. ICON plc
  • 12.6. Signant Health
  • 12.7. MaxisIT Inc.
  • 12.8. 4G Clinical
  • 12.9. Veeva Systems Inc.
  • 12.10. eClinical Solutions LLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13. Strategic Recommendations

14. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 3. Global eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 4. Global eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 5. Global eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 6. Global eClinical Solutions Market Share (%), By Region, 2017-2031F
  • Figure 7. North America eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 8. North America eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 9. North America eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 10. North America eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 11. North America eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 12. North America eClinical Solutions Market Share (%), By Country, 2017-2031F
  • Figure 13. United States eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 14. United States eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 15. United States eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 16. United States eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 17. United States eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 18. Canada eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 19. Canada eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 20. Canada eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 21. Canada eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 22. Canada eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 23. Mexico eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. Mexico eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 25. Mexico eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 26. Mexico eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 27. Mexico eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 28. Europe eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Europe eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 30. Europe eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 31. Europe eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 32. Europe eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 33. Europe eClinical Solutions Market Share (%), By Country, 2017-2031F
  • Figure 34. Germany eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 35. Germany eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 36. Germany eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 37. Germany eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 38. Germany eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 39. France eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 40. France eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 41. France eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 42. France eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 43. France eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 44. Italy eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 45. Italy eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 46. Italy eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 47. Italy eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 48. Italy eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 49. United Kingdom eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 50. United Kingdom eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 51. United Kingdom eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 52. United Kingdom eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 53. United Kingdom eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 54. Russia eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 55. Russia eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 56. Russia eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 57. Russia eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 58. Russia eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 59. Netherlands eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 60. Netherlands eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 61. Netherlands eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 62. Netherlands eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 63. Netherlands eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 64. Spain eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. Spain eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 66. Spain eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 67. Spain eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 68. Spain eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 69. Turkey eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Turkey eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 71. Turkey eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 72. Turkey eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 73. Turkey eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 74. Poland eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Poland eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 76. Poland eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 77. Poland eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 78. Poland eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 79. South America eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 80. South America eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 81. South America eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 82. South America eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 83. South America eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 84. South America eClinical Solutions Market Share (%), By Country, 2017-2031F
  • Figure 85. Brazil eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 86. Brazil eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 87. Brazil eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 88. Brazil eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 89. Brazil eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 90. Argentina eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 91. Argentina eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 92. Argentina eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 93. Argentina eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 94. Argentina eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 95. Asia-Pacific eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Asia-Pacific eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 97. Asia-Pacific eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 98. Asia-Pacific eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 99. Asia-Pacific eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 100. Asia-Pacific eClinical Solutions Market Share (%), By Country, 2017-2031F
  • Figure 101. India eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 102. India eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 103. India eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 104. India eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 105. India eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 106. China eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 107. China eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 108. China eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 109. China eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 110. China eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 111. Japan eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 112. Japan eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 113. Japan eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 114. Japan eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 115. Japan eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 116. Australia eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 117. Australia eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 118. Australia eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 119. Australia eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 120. Australia eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 121. Vietnam eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 122. Vietnam eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 123. Vietnam eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 124. Vietnam eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 125. Vietnam eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 126. South Korea eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 127. South Korea eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 128. South Korea eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 129. South Korea eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 130. South Korea eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 131. Indonesia eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Indonesia eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 133. Indonesia eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 134. Indonesia eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 135. Indonesia eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 136. Philippines eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 137. Philippines eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 138. Philippines eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 139. Philippines eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 140. Philippines eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 141. Middle East & Africa eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 142. Middle East & Africa eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 143. Middle East & Africa eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 144. Middle East & Africa eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 145. Middle East & Africa eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 146. Middle East & Africa eClinical Solutions Market Share (%), By Country, 2017-2031F
  • Figure 147. Saudi Arabia eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 148. Saudi Arabia eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 149. Saudi Arabia eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 150. Saudi Arabia eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 151. Saudi Arabia eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 152. UAE eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 153. UAE eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 154. UAE eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 155. UAE eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 156. UAE eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 157. South Africa eClinical Solutions Market, By Value, In USD Billion, 2017-2031F
  • Figure 158. South Africa eClinical Solutions Market Share (%), By Product, 2017-2031F
  • Figure 159. South Africa eClinical Solutions Market Share (%), By Mode of Delivery, 2017-2031F
  • Figure 160. South Africa eClinical Solutions Market Share (%), By Clinical Trial Phase, 2017-2031F
  • Figure 161. South Africa eClinical Solutions Market Share (%), By End-user, 2017-2031F
  • Figure 162. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 163. By Mode of Delivery Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 164. By Clinical Trial Phase Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 165. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 166. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023